Book description
Methods, Processes, and Tools for Collaboration
"The time has come to fundamentally rethink how we handle the
building of knowledge in biomedical sciences today. This book
describes how the computational sciences have transformed into being a
key knowledge broker, able to integrate and operate across divergent
data types."Â-Bryn Williams-Jones, Associate Research Fellow, Pfizer
The pharmaceutical industry utilizes an extended network of partner
organizations in order to discover and develop new drugs, however
there is currently little guidance for managing information and
resources across collaborations.
Featuring contributions from the leading experts in a range of
industries, Collaborative Computational Technologies for Biomedical
Research provides information that will help organizations make
critical decisions about managing partnerships, including:
-
Serving as a user manual for collaborations
-
Tackling real problems from both human collaborative and data
and informatics perspectives
-
Providing case histories of biomedical collaborations and
technology-specific chapters that balance technological depth
with accessibility for the non-specialist reader
A must-read for anyone working in the pharmaceuticals industry or
academia, this book marks a major step towards widespread
collaboration facilitated by computational technologies.
SEAN EKINS, MSc, PhD, DSc, is the Principal at
Collaborations in Chemistry, and Collaborations Director at
Collaborative Drug Discovery, Inc., as well as an Adjunct Associate
Professor in the Department of Pharmaceutical Sciences, University of
Maryland School of Pharmacy. He has published more than 170 papers and
book chapters on computational and in vitro drug discovery approaches
and has previously edited or co-edited three books for Wiley.
MAGGIE A. Z. HUPCEY, PhD, is a chemist working within the Life
Sciences and Healthcare Practice of PA Consulting Group in Princeton,
New Jersey. She has worked on collaborative projects for the design
and development of new products and processes in the medical device,
drug delivery, and drug discovery fields, including presubmission and
post-launch regulatory compliance activities.
ANTONY J. WILLIAMS, PhD, FRSC, is currently Vice President,
Strategic Development, at the Royal Society of Chemistry and holds an
adjunct position at UNC-Chapel Hill. He has written chapters for many
books and published more than 100 peer-reviewed papers and book
chapters on NMR, predictive ADME methods, Internet-based tools,
crowdsourcing, and database curation. He is an active blogger and
participant in the Internet chemistry network.
